GAFP ONLINE EDUCATIONAL ACTIVITIES
The GAFP continues to expand and offer diverse CME including online CME to family physicians, clinicians, and nurse practitioners. Each lecture includes a pre-test that must be completed before beginning the lecture. Upon completion of a lecture, a post test and evaluation will appear. After completing the pre-test, lecture, post-test, and evaluation, GAFP will email you a certificate for your personal records and as a means of reporting your credits to your appropriate accrediting body. GAFP will report members' credits to the AAFP.
Sickle Cell Disease: New Insights into Management
The lecture, "Sickle Cell Disease: New Insights into Management" was presented during the GAFP's 2012 Annual Scientific Assembly.
Sickle cell disease (SCD), the most common genetic disease screened for in the newborn period, occurs in ?1 in 2400 newborns in the general population and 1 in 400 individuals of African descent in the United States. Despite the relative high prevalence and low pediatric mortality rate of SCD when compared with other genetic diseases or chronic diseases in pediatrics, few evidence-based guidelines have been developed to facilitate the transition from pediatrics to family medicine environment. This activity offers effective tools that can be used to facilitate the transition.
Because young adults with SCD are living longer, the importance of transitioning from a pediatric primary care provider to adult primary care physician has become a critical step in the health care management plan. We identify how the primary care physicians in tandem with the pediatric specialist can enhance transition interventions for children and adolescents with SCD.
At the completion of this session, the participant will be able to:
- Understand the progress in sickle cell disease over the last century
- Learn the impact of newborn screening on prognosis
- Understand the contribution of hydroxyurea
- Understand the challenges of adult life and transitioning into the adult care system
This activity is supported, in part, by an educational grant from Funding for activities was made possible by the Georgia Department of Public Health via the Maternal and Child Health Section/ U.S. Department of Health and Human Services/Health Resources and Services Administration.
Anticoagulation in Atrial Fibrillation - click here
The lecture, "Anticoagulation in Atrial Fibrillation" was presented during the GAFP's 2012 Annual Scientific Assembly.
The overall goal of this lecture was to educate family physicians and their practice teams on anticoagulation in atrial fibrillation in an effort to close gaps between current and ideal care of patients with AFib and stroke risk, whether newly diagnosed or currently on anticoagulation therapy and cover both office re-design and clinical issues.This educational initiative will assist clinicians in primary care, cardiology, hospitalist care, and others working in anticoagulation clinics to better:
- Identify at least 5 risk factors that increase risk of stroke in atrial fibrillation
- List at least 4 different strategies, with 2 pros and cons for each, in order to prevent stroke in atrial fibrillation
Statement of Acknowledgment:
This activity is funded through an educational grant from Bristol-Myers Squibb/Pfizer Pharmaceuticals Partnership to the TEAM-A Collaborative to support activities that improve the treatment of patients with Atrial Fibrillation. The Physicians’ Institute is a member of TEAM-A and retains full control over the distribution of individual grants under this collaborative grant program.
For an array of educational tools designed to meet the needs of healthcare professionals caring for patients with atrial fibrillation needing anticoagulation therapy, please visit http://www.teamanticoag.com. Once on the site, click on the Toolkit tab for a detailed listing of available resources.Additional Atrial Fibrillation Resources